...
首页> 外文期刊>Environmental Pollution >Insights on the biological role of ultrafine particles of size PM_(<0.25): A prospective study from New Delhi
【24h】

Insights on the biological role of ultrafine particles of size PM_(<0.25): A prospective study from New Delhi

机译:关于超细颗粒的尺寸PM _(<0.25)的生物学作用的见解:新德里的前瞻性研究

获取原文
获取原文并翻译 | 示例

摘要

When the total ambient PM2.5 levels are several-fold higher than the recommended limit, it may be important to study the distributions of different sizes of particulate matter (PM). Here, we assess the distributions of various sizes of total PM2.5 for 12 months (on a monthly basis) in New Delhi, India. Importantly, we found that ultrafine particles (i.e., particles 0.5 mu m) contribute significantly to total PM2.5. PM0.25 were the most cytotoxic particles to human lung epithelial cells in all the 12 months. In addition, PM0.25 were associated with significantly higher cytotoxicity per unit mass compared to other size fractions constituting PM2.5. For any given size of PM, the amount of reactive oxygen species (ROS) generated per unit mass is higher for the month of March as compared to that for the rest of the months in the year. The higher ROS generations for all sizes of PM collected in the month of March was not explained by differences in their metal content values. Our data suggests the lack of correlation between total PM2.5 levels and the highly cytotoxic PM0.25. In summary, this work establishes the need for policy changes to routinely monitor PM0.25 and the necessity to establish exposure limits for PM0.25, especially when the total PM2.5 levels are breached. (C) 2020 Published by Elsevier Ltd.
机译:当总环境PM2.5水平高于推荐极限时,研究不同尺寸的颗粒物质(PM)的分布可能是很重要的。在这里,我们在印度新德里评估各种规模的总PM2.5的分布为12个月(按每月)。重要的是,我们发现超细颗粒(即,颗粒<0.5μm)显着贡献至总PM2.5。 PM <0.25在12个月内是人肺上皮细胞的最多细胞毒性颗粒。此外,与构成PM2.5的其他尺寸级分相比,PM <0.25与每单位质量显着更高的细胞毒性相关。对于任何给定的PM尺寸,与本年度余下的月份相比,3月份产生的反应性氧物质(ROS)的量较高。在3月份收集的所有尺寸的PM较高的ROS几代人未被金属含量值的差异解释。我们的数据表明总PM2.5水平与高细胞毒性PM <0.25之间缺乏相关性。总之,这项工作确定了对政策变化的需求,以定期监测PM <0.25,以及建立PM <0.25的暴露限值的必要性,特别是当突破总PM2.5水平时。 (c)2020由elestvier有限公司发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号